PETS - PetMed Express, Inc.
| Previous Close | 15.09 |
| Open | 15.38 |
| Bid | 16.09 x 1000 |
| Ask | 16.10 x 800 |
| Day's Range | 15.38 - 16.28 |
| 52 Week Range | 15.00 - 41.76 |
| Volume | 1,388,243 |
| Avg. Volume | 691,174 |
| Market Cap | 324.496M |
| Beta (3Y Monthly) | 0.83 |
| PE Ratio (TTM) | 8.76 |
| EPS (TTM) | 1.84 |
| Earnings Date | Jul 22, 2019 |
| Forward Dividend & Yield | 1.08 (7.20%) |
| Ex-Dividend Date | 2019-05-16 |
| 1y Target Est | 18.67 |
- GlobeNewswire•7 hours ago
PetMed Express d/b/a 1-800-PetMeds to Announce Its First Quarter Financial Results on July 22, 2019
PetMed Express, Inc. (PETS) will announce its financial results for the quarter ended June 30, 2019 on Monday, July 22, 2019 at 8:00 A.M. Eastern Time, then at 8:30 A.M. Eastern Time, Menderes Akdag, the Company’s Chief Executive Officer and President, will host a conference call to review the financial results. For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. Eastern Time on July 22, 2019 until August 5, 2019 at 11:59 P.M. Eastern Time. Founded in 1996, PetMed Express is America’s Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.
- GuruFocus.com•5 days ago
2nd-Quarter 2019 Performance Review
A review of Nintai Investments' performance and thoughts on the markets
- MarketWatch•12 days ago
A recession-proof industry you can count on: pet care
Recession-proof industries are unique. They sell stuff that people buy no matter what’s happening in the economy — things like electricity, internet access, toilet paper. And now pet care. That’s right: America is pet obsessed.
- Simply Wall St.•14 days ago
Who Has Been Selling PetMed Express, Inc. (NASDAQ:PETS) Shares?
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
- Insider Monkey•18 days ago
Do Hedge Funds Really Like Petmed Express Inc (PETS)?
Petmed Express Inc (NASDAQ:PETS) was in 16 hedge funds' portfolios at the end of the first quarter of 2019. PETS investors should be aware of an increase in enthusiasm from smart money in recent months. There were 15 hedge funds in our database with PETS holdings at the end of the previous quarter. Our calculations […]
- Simply Wall St.•last month
Why Fundamental Investors Might Love PetMed Express, Inc. (NASDAQ:PETS)
PetMed Express, Inc. (NASDAQ:PETS) is a company with exceptional fundamental characteristics. Upon building up an...
- Motley Fool•last month
3 Unknown but Amazing Dividend Stocks
These dividend stocks are flying under the radar relative to bigger names, and that could spell opportunity for investors.
- Benzinga•last month
A Look At PetMed Express Through Benzinga's Securities Lending Volatility Index
Benzinga’s Securities Lending Volatility Index (SLVX) Powered by Tidal Markets, is an indicator that forecasts stock market activity for broader indices and individual securities. As an example of the SLVX's utility as a stock market indicator, take a look at how changes in the SLVX anticipated a -27.53 percent decline in PetMed Express over 32 trading days between April and May 2019. PetMed Express, Inc. (NASDAQ: PETS) and its subsidiaries operate as a pet pharmacy in the United States.
- GuruFocus.com•2 months ago
PetMed Express Inc (PETS) Files 10-K for the Fiscal Year Ended on March 31, 2019
PetMed Express Inc (NASDAQ:PETS) files its latest 10-K with SEC for the fiscal year ended on March 31, 2019.
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of PETS earnings conference call or presentation 6-May-19 12:30pm GMT
Q4 2018 Petmed Express Inc Earnings Call
- Insider Monkey•2 months ago
Here’s What Hedge Funds Think About Petmed Express Inc (PETS)
Is Petmed Express Inc (NASDAQ:PETS) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, expert networks, and get tips from investment bankers and industry insiders. Sure they sometimes fail miserably but historically their consensus stock […]
- InvestorPlace•2 months ago
7 Dangerous Dividend Stocks to Stay Far Away From
Even in a broad market near all-time highs, it hasn't been a great time to be an income investor. Dividend stocks largely have underperformed. The winners this decade generally have been tech and/or growth stocks, most of which don't pay dividends. Adding insult to injury, of late there have been several high-profile dividend cuts in widely owned names.General Electric (NYSE:GE) in fact cut its dividend in both 2017 and 2018. It now pays just a penny per share each quarter. Owens & Minor (NYSE:OMI), a seemingly safe healthcare distributor that like GE was slow to adapt to changes in its industry, similarly executed a double cut, to just $0.0025 (a penny per year). Anheuser-Busch InBev (NYSE:BUD) halved its payout last year to attack its debt load. Frontier Communications (NASDAQ:FTR) and Mattel (NASDAQ:MAT) eliminated their dividends for similar reasons.All stocks wound up being yield traps -- dividend stocks that investors bought for yield, only to wind up losing both income and principal as the stocks fell. They are reminders that buying a stock just for its dividend is a risky, and even dangerous, strategy. An investor owning a stock needs to focus on the company -- not a single metric.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Great Stocks to Buy on Dips These 7 dividend stocks may not join the list of companies who cut their dividends soon -- or ever. But they are among the riskier stocks for income investors at the moment. An attractive dividend isn't so attractive when principal shrinks, offsetting those payouts. And all 7 of these dividend stocks seem to be at serious risk of at least seeing share price declines that will offset the high yields they offer at the moment. AT&T (T)Source: Shutterstock AT&T (NYSE:T) appears to be an income investor's dream. T stock has been a "widows and orphans" stock since the days when it was still 'Ma Bell'. Even after the breakup, the move into cellular service, and the acquisition of Time Warner, AT&T stock still looks like a great dividend stock.It yields 6.67%, and in December announced its 35th consecutive annual increase, making T stock a so-called Dividend Aristocrat. That dividend still represents only about 57% of projected 2019 EPS, a reasonable payout ratio that leaves some room for AT&T to pay down its massive debt load.But I've long been skeptical toward AT&T stock -- and I continue to be so. The attractive dividend continues to be offset by a tumbling T stock price. Over the last five years, including dividends, AT&T stock has returned a little over 12% -- total. It's not just underperformed the market, it's barely outperformed Treasury bills at a time of historically low interest rates. Over the past year, T investors have made barely 1%; over the last three years, they've lost money including dividends while the S&P 500 has returned nearly 50% on the same basis.Simply put, T has been a disappointing investment. Looking forward, it's not clear how that is supposed to change. The cellular business is brutally competitive and at this point low-growth. The wireline business is declining. So is DIRECTV, and streaming service DIRECTV NOW is losing customers.Outside of HBO, Time Warner -- now WarnerMedia -- faces a real threat from cord-cutting. And AT&T' new streaming service seems unlikely to outcompete Disney (NYSE:DIS) and Netflix (NASDAQ:NFLX), let alone Comcast (NASDAQ:CMCSA).AT&T may keep its dividend rising. But that's been of little help to shareholders for most of this decade, and I'm skeptical that will change in the next one. Macerich (MAC)Source: Shutterstock Shopping mall REIT Macerich (NYSE:MAC) has offered an attractive yield for years now -- yet MAC stock keeps heading in the wrong direction. MAC trades near its lowest levels in almost eight years -- a decline that has driven the stock's dividend yield above 7%.At these levels, the dividend stock does look potentially attractive. MAC trades at a little over 11x the midpoint of 2019 guidance for FFO (funds from operations, a common adjusted net income figure used by REITs). The dividend yield is healthy. Support for the stock around $40 seems to have held since December. And the company's higher-end properties -- what it calls "fortress malls" -- in theory should better manage the changes in U.S. shopping patterns and the steady growth of e-commerce.The problem is that the same case could have been made for the past few years. Yet MAC's yield continued to creep up, touching 5% in 2017, 6% last year, and 7% this year. It's not higher payouts driving those increases (though Macerich has managed to increase its payout modestly in recent years). Rather, the declining MAC share price has driven those yields higher.The same phenomenon has played out elsewhere in the mall space, notably with lower-quality rivals Washington Prime (NYSE:WPG) and CBL & Associates (NYSE:CBL). Macerich still has a reasonably large debt load, and with the dividend payout about 80% of FFO, it may freeze increases or cut the payout to attack those borrowings. And any economic weakness can hit occupancy and cause real problems going forward. * 5 Clean Energy ETFs to Buy for 2019 Macerich might look like it's at a bottom, but investors have believed that before, and been wrong in doing so. Occidental Petroleum (OXY)Source: Hayden Irwin via FlickrOccidental Petroleum (NYSE:OXY) is making a big bet on U.S. shale, with some help from Warren Buffett and Berkshire Hathaway (NYSE:BRK.A,NYSE:BRK.B). Backed by the issuance of $10 billion in preferred stock to Berkshire, Occidental seems likely to win its bidding war with Chevron (NYSE:CVX) for shale driller Anadarko Petroleum (NYSE:APC).Whether that's good news for OXY stock remains to be seen. So far, investors seem displeased. OXY has sold off in recent sessions, and trades not far from multi-year lows. But, again, OXY is making a big bet, paying an estimated $38 billion for Anadarko against its current market capitalization of $44 billion. It is a high-risk play -- but one that also will offer high rewards if rising optimism toward U.S. shale proves correct.But for dividend stock investors, the deal raises a clear risk toward Occidental's payout. Analysts at Mizuho pointed out that dividend coverage may not be sufficient, particularly as the acquisition is integrated. Meanwhile, the Berkshire deal alone adds some $800 million in annual preferred stock distributions.And so it wouldn't be a surprise if Oxy cut or eliminated its dividend. Much like Anheuser-Busch after its takeover of SABMiller, Occidental will have significantly higher interest and distribution payments -- and may choose to redirect cash flow toward deleveraging. That might be the right play long-term - but it raises a significant near- to mid-term risk to the Occidental dividend, and thus to OXY stock. Weaker oil prices would only add to the pressure.Again, this isn't to say OXY stock is a short. But income investors looking for energy exposure have a better and hedged option in larger Exxon Mobil (NYSE:XOM). At this point, OXY is much more of a speculative play -- and not a stock to be owned just because it's a dividend stock. PetMed Express (PETS)Source: Shutterstock I've long thought online pet retailer PetMed Express (NASDAQ:PETS) was attractive at the right price. But after recent results, the risks are clear, even with PETS offering a 5.5% yield.Chewy.com, now owned by Petsmart, is entering the online pet prescription space in a big way. And it's clearly taking share from PetMed Express. Revenue was flat year-over-year in fiscal Q3 (the December quarter), a notable deceleration from recent performance. In Q4, sales dropped 4% - despite sharply higher advertising spend. Lower sales and higher spending drove EPS down 35% in the quarter - and sets up a difficult fiscal 2020 for the company. * 5 Big Announcements From Google I/O 2019 PETS may be able to maintain its dividend: the company still has nearly $5 per share in cash on the balance sheet, and no debt. But with sales and margin pressure almost certain to continue into 2020, even a 5%+ payout isn't enough to take the risk that PETS shares will keep falling. Coca-Cola (KO)Source: Leo Hidalgo via Flickr (Modified)To be sure, Coca-Cola (NYSE:KO) might be in the best spot of any stock our list of dividend stocks -- at least on a relative basis. It doesn't have the debt problems of AT&T. Rival Pepsi (NASDAQ:PEP) is unlikely to take huge amount of market share, even if smaller sparkling water companies and other alternative beverage producers might. Even Coca-Cola's history is better: the stock is a Dividend King, a designation for companies who have raised their dividends for at least 50 consecutive years.But dividend aside, KO stock seems a risky play here. It trades at over 21x next year's consensus EPS -- despite the fact that earnings haven't grown for years. Soda consumption is plunging. The $5 billion acquisition of a coffee chain doesn't diversify the $200 billion-plus company enough away from that issue. KO simply looks overvalued, as I argued in March.More broadly, as I noted last year, there's also the fact that a number of stocks similar to KO have taken big hits of late. Branded consumer products stocks like Coca-Cola historically have been attractive, and safe, long-term income plays. (Berkshire Hathaway, of course, has made billions off its stake in the company.)But those 'safe' stocks don't look all that safe anymore. BUD shares tumbled last year, and still haven't recovered their gains. Altria (NYSE:MO) lost a third of its value in less than three months. Kraft Heinz (NASDAQ:KHC) is a mess and trades at post-merger lows. Campbell Soup (NYSE:CPB) doesn't look much better.Tastes are changing. Healthy offerings and independent brands are hot right now -- and that may not change. If it doesn't, KO's earnings are going to stay stagnant at best -- and at some point, investors are going to stop pricing growth into Coca-Cola shares. Western Digital (WDC)Source: Shutterstock Investors spent the second half of 2018 worrying that earnings at chip stocks and memory plays like Western Digital (NASDAQ:WDC) were going to plunge. They've spent the first months of 2019 shrugging now that the earnings declines finally have arrived. WDC's Q3 earnings missed badly, with adjusted EPS of $0.17 missing consensus estimates of $0.46 and declining a stunning 95% year-over-year.The drop in earnings isn't necessarily fatal to the bull case for WDC stock. Memory is a cyclical business due to volatile pricing, and it certainly seems like pricing is closer to a bottom than a top. But I wrote in March, with WDC at similar levels, that investors were underestimating the risks here -- and the Q3 report strengthens that argument.Meanwhile, Western Digital's dividend may be at risk. EPS estimates for FY20 are now under $4 - suggesting a payout ratio climbing above 50%. The company still has over $10 billion in debt that needs to be managed. If expectations for next year keep coming down, Western Digital could choose to cut or eliminate its payout to focus on deleveraging. Analysts at Evercore (NYSE:EVR) made exactly that argument in a note in January -- and it sent Western Digital stock tumbling. * 7 Marijuana Stocks That Are Bleeding Cash A dividend cut combined with lowered earnings expectations would be something close to a disaster for WDC stock. Given that the dividend stock has bounced over 40% from December lows, it might be time for investors to take profits. Income investors, in particular, may want to look past a yield that now clears 4%. New Media (NEWM)Source: Shutterstock New Media Investment Group (NYSE:NEWM) seems like an intriguing high-yield play. New Media buys local and mid-sized newspapers, presumably on the cheap, and then uses its scale to cut costs and wring out profits. A decent amount of those profits go back to investors, or so it seems: NEWM yields nearly 15% at the moment.But there are several problems with this story -- and one big one for income investors. New Media isn't actually funneling profits to investors. Rather, it's funding the dividend through steady issuance of NEWM stock -- usually at below-market prices. These offerings also involve hefty incentive fees for , New Media's external manager. (Fortress now is owned by Softbank (OTCMKTS:SFTBY).)And so investors aren't really 'earning' a dividend. Rather, their ownership is being diluted for cash. With NEWM stock now at an all-time low, it seems like the market finally is catching on.But even those lows don't look low enough. I called NEWM stock 'toxic' a year ago and still believe that's the case. Unsurprisingly, New Media's revenue and profits keep falling outside of the contribution from acquisitions. The strategy is the same that sent predecessor GateHouse Media into bankruptcy. And the company still is buying yet more papers, instead of using a 'cigar butt' strategy that focuses on returning actual cash to shareholders, not just selling NEWM shares to fund more acquisitions.As such, NEWM looks like a true yield trap. A 15% yield might seem attractive, but it's unlikely to last unless New Media changes its strategy, and its ways.As of this writing, Vince Martin has no positions in any securities mentioned. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Great Stocks to Buy on Dips * 6 Growth Stocks to Buy for the Rest of 2019 * 4 Mega-Cap Stocks to Sell Before They Melt Down Compare Brokers The post 7 Dangerous Dividend Stocks to Stay Far Away From appeared first on InvestorPlace.
- Simply Wall St.•2 months ago
Calculating The Intrinsic Value Of PetMed Express, Inc. (NASDAQ:PETS)
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Today we will run through one way of estimating the intrinsic value of PetMed Express, Inc. (NASDAQ:P...
- Motley Fool•2 months ago
Why PetMed Express, Chemours, and Affiliated Managers Group Slumped Today
Earnings, analysts, and other concerns hurt these stocks.
- InvestorPlace•2 months ago
PetMed Express Earnings: PETS Stock Plunges on Q4 Miss
PetMed Express earnings for the company's fiscal fourth quarter of 2019 have PETS stock falling hard on Monday.Source: Shutterstock PetMed Express (NASDAQ:PETS) earnings for its fiscal fourth quarter of the year include earnings per share of 32 cents. This is a major drop from the company's earnings per share of 50 cents from the same time last year. It was also a blow to PETS stock by missing Wall Street's earnings per share estimate of 46 cents for the period.The PetMed Express earnings report for its fiscal fourth quarter of 2019 has net income coming in at $6.62 million. This is down from the company's net income of $10.18 million reported in its fiscal fourth quarter of 2018.InvestorPlace - Stock Market News, Stock Advice & Trading TipsOperating income reported in the PetMed Express earnings release for its fiscal fourth quarter of the year comes in at $7.80 million. That's a decrease from the company's operating income of $14.49 million reported in the same period of the year prior.PetMed Express earnings for the company's fiscal fourth quarter of the year also include revenue of $64.57 million. This is worse than the company's revenue of $67.32 million reported in its fiscal fourth quarter of the previous year. Unfortunately for PETS stock, this also doesn't meet analysts' revenue estimate of $69.06 million for the quarter. * 7 Energy Stocks to Buy to Light Up Your Portfolio The most recent PetMed Express earnings report also has it announcing a dividend of 27 cents per share. This dividend will be payable on May 24, 2019 to investors that are on record as of May 17, 2019.PETS stock was down 8% as of Monday afternoon. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Energy Stocks to Buy to Light Up Your Portfolio * 10 Vice Stocks to Spice Up Your Portfolio * 7 of the Best ETFs to Buy for a Slowing Economy As of this writing, William White did not hold a position in any of the aforementioned securities.Compare Brokers The post PetMed Express Earnings: PETS Stock Plunges on Q4 Miss appeared first on InvestorPlace.
Motley Fool•2 months agoPetMed Express Inc (PETS) Q4 2018 Earnings Call Transcript
PETS earnings call for the period ending March 31, 2019.
- Associated Press•2 months ago
PetMed: Fiscal 4Q Earnings Snapshot
On a per-share basis, the Delray Beach, Florida-based company said it had net income of 32 cents. The pet pharmacy company posted revenue of $64.6 million in the period. For the year, the company reported ...
- GlobeNewswire•2 months ago
PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Its Fourth Quarter and Fiscal Year End Financial Results and Declares Its $0.27 Per Share Dividend
DELRAY BEACH, Fla., May 06, 2019 -- PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the fiscal year ended March 31, 2019. Net sales for the.
- Motley Fool•3 months ago
A New PetMed Express Trick: Rolling Over and Playing Dead
Recent results have put PetMed Express in the doghouse. Is this an opportunity for investors?
- TheStreet.com•3 months ago
This Portfolio of Comeback Kids Continues to Hold Its Own
Results from my 2018 tax-loss-selling rebound tracking portfolio improved slightly over the last month, although its advantage over my selected benchmarks -- the S&P 500 and Russell 2000 -- has narrowed as the two indices had a solid month.
- GlobeNewswire•3 months ago
PetMed Express D/B/A 1-800-PetMeds to Announce Its Fiscal Year End Financial Results on May 6, 2019
PetMed Express, Inc. (PETS) will announce its financial results for the fiscal year ended March 31, 2019 on Monday, May 6, 2019 at 8:00 A.M. Eastern Time, then at 8:30 A.M. Eastern Time, Menderes Akdag, the Company’s Chief Executive Officer and President, will host a conference call to review the financial results. For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. Eastern Time on May 6, 2019 until May 20, 2019 at 11:59 P.M. Eastern Time. To access the replay, call (866) 465-0340 (toll free) or (203) 369-1417, and enter passcode 5500.
- Simply Wall St.•3 months ago
A Closer Look At PetMed Express, Inc.'s (NASDAQ:PETS) Impressive ROE
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. We'll use ROE to examine PetMe...
- Simply Wall St.•4 months ago
Introducing PetMed Express, A Stock That Climbed 58% In The Last Five Years
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the market average. And in our experience, buying the right stocksRead More...
- GlobeNewswire•5 months ago
Report: Exploring Fundamental Drivers Behind Crocs, Portola Pharmaceuticals, ANSYS, Alpha and Omega Semiconductor, PetMed Express, and MYOS RENS Technology — New Horizons, Emerging Trends, and Upcoming Developments
NEW YORK, Feb. 19, 2019 -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders,.
- Simply Wall St.•5 months ago
What Makes PetMed Express, Inc. (NASDAQ:PETS) A Great Dividend Stock?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! If you are an income investor, thenRead More...
